Compare $MCRB vs $SHPH | Chartloom

Compare

$MCRB vs $SHPH

Seres Therapeutics Inc · Shuttle Pharmaceuticals Holdings Inc

MCRB

Seres Therapeutics Inc

SHPH

Shuttle Pharmaceuticals Holdings Inc

Compare $MCRB vs $SHPH

Comparing Seres Therapeutics Inc and Shuttle Pharmaceuticals Holdings Inc

MCRBSeres Therapeutics Inc

SHPHShuttle Pharmaceuticals Holdings Inc

MCRBSeres Therapeutics Inc

Market cap

$26M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-82.1%

52W performance

-86.2%

FCF yield

-195.5%

SHPHShuttle Pharmaceuticals Holdings Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-70.6%

52W performance

-87.9%

FCF yield

-283.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MCRB

SHPH

Detailed metrics comparison

MCRB

Seres Therapeutics Inc

SHPH

Shuttle Pharmaceuticals Holdings Inc

Market Cap

MCRB$26M

SHPH$3M

Enterprise Value

MCRB$11M

SHPH$3M

Price

MCRB$2.71

SHPH$5.33

P/E Ratio

MCRBN/A

SHPHN/A

P/S Ratio

MCRB13.93x

SHPH0.00x

EV/Sales

MCRB5.65x

SHPH0.00x

EV/EBITDA

MCRB0.00x

SHPH0.00x

P/B Ratio

MCRB0.85x

SHPH5.94x

P/FCF Ratio

MCRBN/A

SHPHN/A

EV/FCF

MCRB-0.21x

SHPH-0.34x

PEG Ratio

MCRBN/A

SHPHN/A

Forward P/E (NTM)

MCRBN/A

SHPHN/A

Forward P/S (NTM)

MCRBN/A

SHPHN/A

Revenue (TTM)

MCRB$2M

SHPH$0

Revenue Growth (YoY)

MCRBN/A

SHPHN/A

Forward Rev Growth

MCRB-98.0%

SHPH0.0%

Gross Margin (TTM)

MCRB0.0%

SHPH0.0%

Operating Margin (TTM)

MCRB0.0%

SHPH0.0%

EBITDA Margin (TTM)

MCRB-3971.2%

SHPH0.0%

Net Margin (TTM)

MCRB-1192.9%

SHPH0.0%

FCF Margin (TTM)

MCRB-2724.1%

SHPHN/A

Net Income (TTM)

MCRB$-22M

SHPH$-10M

FCF (TTM)

MCRB$-51M

SHPH$-10M

EPS (TTM)

MCRB-$2.30

SHPH-$10.11

ROE (TTM)

MCRB-6032.0%

SHPH-40833.0%

ROA (TTM)

MCRB-1794.0%

SHPH-13815.0%

ROIC (TTM)

MCRB-6032.0%

SHPH-37757.0%

Cash

MCRB$16M

SHPH$90K

Debt

MCRB$0

SHPH$0

Net Cash/Debt

MCRB$16M

SHPH$90K

Current Ratio (TTM)

MCRB2.11x

SHPH0.30x

Quick Ratio (TTM)

MCRB2.04x

SHPH0.13x

Debt/Equity (TTM)

MCRB0.00x

SHPH1.23x

Debt/Assets (TTM)

MCRB0.0%

SHPH0.0%

Interest Coverage (TTM)

MCRBN/A

SHPHN/A

Net Debt/EBITDA (TTM)

MCRB0.00x

SHPH0.00x

Beta

MCRB0.49

SHPH1.13

52W Performance

MCRB-86.2%

SHPH-87.9%

YTD Performance

MCRB-82.1%

SHPH-70.6%

% from 52W High

MCRB-91.0%

SHPH-90.5%

% from 52W Low

MCRB12.0%

SHPH106.9%

Asset Turnover (TTM)

MCRB0.02x

SHPH0.00x

FCF Yield (TTM)

MCRB-195.5%

SHPH-283.7%

Earnings Yield (TTM)

MCRB-85.6%

SHPH-300.8%

Dividend Yield (TTM)

MCRBN/A

SHPHN/A

Rule of 40

MCRB-2,724.1

SHPH0.0

EV/GP/RG

MCRBN/A

SHPHN/A

Ticker research

View MCRB research View SHPH research

Metric	MCRB Seres Therapeutics Inc	SHPH Shuttle Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$26M	$3M
Enterprise Value	$11M	$3M
Price	$2.71	$5.33
P/E Ratio	N/A	N/A
P/S Ratio	13.93x	0.00x
EV/Sales	5.65x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	5.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.21x	-0.34x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-98.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3971.2%	0.0%
Net Margin (TTM)	-1192.9%	0.0%
FCF Margin (TTM)	-2724.1%	N/A
Net Income (TTM)	$-22M	$-10M
FCF (TTM)	$-51M	$-10M
EPS (TTM)	-$2.30	-$10.11
ROE (TTM)	-6032.0%	-40833.0%
ROA (TTM)	-1794.0%	-13815.0%
ROIC (TTM)	-6032.0%	-37757.0%
Financial Health
Cash	$16M	$90K
Debt	$0	$0
Net Cash/Debt	$16M	$90K
Current Ratio (TTM)	2.11x	0.30x
Quick Ratio (TTM)	2.04x	0.13x
Debt/Equity (TTM)	0.00x	1.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.49	1.13
52W Performance	-86.2%	-87.9%
YTD Performance	-82.1%	-70.6%
% from 52W High	-91.0%	-90.5%
% from 52W Low	12.0%	106.9%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-195.5%	-283.7%
Earnings Yield (TTM)	-85.6%	-300.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,724.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MCRB research	View SHPH research

Valuation

P/S Ratio

SHPH

0.00x

MCRB

13.93x

EV/FCF

SHPH

-0.34x

MCRB

-0.21x

Growth & revenue

Forward Revenue Growth

SHPH

0.0%

MCRB

-98.0%

Profitability & performance

Gross Margin

MCRB

0.0%

SHPH

0.0%

ROE

MCRB

-6032.0%

SHPH

-40833.0%

FCF Yield %

MCRB

-195.5%

SHPH

-283.7%

52-Week Performance

MCRB

-86.2%

SHPH

-87.9%

Detailed metrics comparison

MCRB

Seres Therapeutics Inc

SHPH

Shuttle Pharmaceuticals Holdings Inc

Market Cap

MCRB$26M

SHPH$3M

Enterprise Value

MCRB$11M

SHPH$3M

Price

MCRB$2.71

SHPH$5.33

P/E Ratio

MCRBN/A

SHPHN/A

P/S Ratio

MCRB13.93x

SHPH0.00x

EV/Sales

MCRB5.65x

SHPH0.00x

EV/EBITDA

MCRB0.00x

SHPH0.00x

P/B Ratio

MCRB0.85x

SHPH5.94x

P/FCF Ratio

MCRBN/A

SHPHN/A

EV/FCF

MCRB-0.21x

SHPH-0.34x

PEG Ratio

MCRBN/A

SHPHN/A

Forward P/E (NTM)

MCRBN/A

SHPHN/A

Forward P/S (NTM)

MCRBN/A

SHPHN/A

Revenue (TTM)

MCRB$2M

SHPH$0

Revenue Growth (YoY)

MCRBN/A

SHPHN/A

Forward Rev Growth

MCRB-98.0%

SHPH0.0%

Gross Margin (TTM)

MCRB0.0%

SHPH0.0%

Operating Margin (TTM)

MCRB0.0%

SHPH0.0%

EBITDA Margin (TTM)

MCRB-3971.2%

SHPH0.0%

Net Margin (TTM)

MCRB-1192.9%

SHPH0.0%

FCF Margin (TTM)

MCRB-2724.1%

SHPHN/A

Net Income (TTM)

MCRB$-22M

SHPH$-10M

FCF (TTM)

MCRB$-51M

SHPH$-10M

EPS (TTM)

MCRB-$2.30

SHPH-$10.11

ROE (TTM)

MCRB-6032.0%

SHPH-40833.0%

ROA (TTM)

MCRB-1794.0%

SHPH-13815.0%

ROIC (TTM)

MCRB-6032.0%

SHPH-37757.0%

Cash

MCRB$16M

SHPH$90K

Debt

MCRB$0

SHPH$0

Net Cash/Debt

MCRB$16M

SHPH$90K

Current Ratio (TTM)

MCRB2.11x

SHPH0.30x

Quick Ratio (TTM)

MCRB2.04x

SHPH0.13x

Debt/Equity (TTM)

MCRB0.00x

SHPH1.23x

Debt/Assets (TTM)

MCRB0.0%

SHPH0.0%

Interest Coverage (TTM)

MCRBN/A

SHPHN/A

Net Debt/EBITDA (TTM)

MCRB0.00x

SHPH0.00x

Beta

MCRB0.49

SHPH1.13

52W Performance

MCRB-86.2%

SHPH-87.9%

YTD Performance

MCRB-82.1%

SHPH-70.6%

% from 52W High

MCRB-91.0%

SHPH-90.5%

% from 52W Low

MCRB12.0%

SHPH106.9%

Asset Turnover (TTM)

MCRB0.02x

SHPH0.00x

FCF Yield (TTM)

MCRB-195.5%

SHPH-283.7%

Earnings Yield (TTM)

MCRB-85.6%

SHPH-300.8%

Dividend Yield (TTM)

MCRBN/A

SHPHN/A

Rule of 40

MCRB-2,724.1

SHPH0.0

EV/GP/RG

MCRBN/A

SHPHN/A

Ticker research

View MCRB research View SHPH research

Metric	MCRB Seres Therapeutics Inc	SHPH Shuttle Pharmaceuticals Holdings Inc
Market & Valuation
Market Cap	$26M	$3M
Enterprise Value	$11M	$3M
Price	$2.71	$5.33
P/E Ratio	N/A	N/A
P/S Ratio	13.93x	0.00x
EV/Sales	5.65x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.85x	5.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.21x	-0.34x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	-98.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3971.2%	0.0%
Net Margin (TTM)	-1192.9%	0.0%
FCF Margin (TTM)	-2724.1%	N/A
Net Income (TTM)	$-22M	$-10M
FCF (TTM)	$-51M	$-10M
EPS (TTM)	-$2.30	-$10.11
ROE (TTM)	-6032.0%	-40833.0%
ROA (TTM)	-1794.0%	-13815.0%
ROIC (TTM)	-6032.0%	-37757.0%
Financial Health
Cash	$16M	$90K
Debt	$0	$0
Net Cash/Debt	$16M	$90K
Current Ratio (TTM)	2.11x	0.30x
Quick Ratio (TTM)	2.04x	0.13x
Debt/Equity (TTM)	0.00x	1.23x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.49	1.13
52W Performance	-86.2%	-87.9%
YTD Performance	-82.1%	-70.6%
% from 52W High	-91.0%	-90.5%
% from 52W Low	12.0%	106.9%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-195.5%	-283.7%
Earnings Yield (TTM)	-85.6%	-300.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,724.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MCRB research	View SHPH research